Teva Pharmaceuticals has voluntarily recalled over 580,000 bottles of its Prazosin Hydrochloride blood pressure capsules after FDA tests found elevated levels of potentially cancer-causing chemicals.
The recall was issued on October 7 after tests found that 1, 2, and 5 mg Prazosin capsules distributed nationwide contained "above acceptable intake limits" of the cancer-linked impurity N-nitroso Prazosin impurity C.
